-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Regenerx Biopharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2022.
- Regenerx Biopharmaceuticals Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$189K, a 38.2% increase year-over-year.
- Regenerx Biopharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$941K, a 5.01% increase from 2021.
- Regenerx Biopharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$990K, a 1.65% increase from 2020.
- Regenerx Biopharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$1.01M, a 11.5% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)